Cargando…
Ureaplasma parvum Serovar 3 Multiple Banded Antigen Size Variation after Chronic Intra-Amniotic Infection/Colonization
Ureaplasma species are the microorganisms most frequently associated with adverse pregnancy outcomes. The multiple banded antigen (MBA), a surface-exposed lipoprotein, is a key virulence factor of ureaplasmas. The MBA demonstrates size variation, which we have shown previously to be correlated with...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637154/ https://www.ncbi.nlm.nih.gov/pubmed/23638142 http://dx.doi.org/10.1371/journal.pone.0062746 |
_version_ | 1782267418498826240 |
---|---|
author | Robinson, James W. Dando, Samantha J. Nitsos, Ilias Newnham, John Polglase, Graeme R. Kallapur, Suhas G. Pillow, J. Jane Kramer, Boris W. Jobe, Alan H. Payton, Diane Knox, Christine L. |
author_facet | Robinson, James W. Dando, Samantha J. Nitsos, Ilias Newnham, John Polglase, Graeme R. Kallapur, Suhas G. Pillow, J. Jane Kramer, Boris W. Jobe, Alan H. Payton, Diane Knox, Christine L. |
author_sort | Robinson, James W. |
collection | PubMed |
description | Ureaplasma species are the microorganisms most frequently associated with adverse pregnancy outcomes. The multiple banded antigen (MBA), a surface-exposed lipoprotein, is a key virulence factor of ureaplasmas. The MBA demonstrates size variation, which we have shown previously to be correlated with the severity of chorioamnion inflammation. We aimed to investigate U. parvum serovar 3 pathogenesis in vivo, using a sheep model, by investigating: MBA variation after long term (chronic) and short term (acute) durations of in utero ureaplasma infections, and the severity of chorioamnionitis and inflammation in other fetal tissues. Inocula of 2×10(7) colony-forming-units (CFU) of U. parvum serovar 3 (Up) or media controls (C) were injected intra-amniotically into pregnant ewes at one of three time points: day 55 (69d Up, n = 8; C69, n = 4); day 117 (7d Up, n = 8; C7, n = 2); and day 121 (3d Up, n = 8; C3, n = 2) of gestation (term = 145–150d). At day 124, preterm fetuses were delivered surgically. Samples of chorioamnion, fetal lung, and umbilical cord were: (i) snap frozen for subsequent ureaplasma culture, and (ii) fixed, embedded, sectioned and stained by haematoxylin and eosin stain for histological analysis. Selected fetal lung clinical ureaplasma isolates were cloned and filtered to obtain cultures from a single CFU. Passage 1 and clone 2 ureaplasma cultures were tested by western blot to demonstrate MBA variation. In acute durations of ureaplasma infection no MBA variants (3d Up) or very few MBA variants (7d Up) were present when compared to the original inoculum. However, numerous MBA size variants were generated in vivo (alike within contiguous tissues, amniotic fluid and fetal lung, but different variants were present within chorioamnion), during chronic, 69d exposure to ureaplasma infection. For the first time we have shown that the degree of ureaplasma MBA variation in vivo increased with the duration of gestation. |
format | Online Article Text |
id | pubmed-3637154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36371542013-05-01 Ureaplasma parvum Serovar 3 Multiple Banded Antigen Size Variation after Chronic Intra-Amniotic Infection/Colonization Robinson, James W. Dando, Samantha J. Nitsos, Ilias Newnham, John Polglase, Graeme R. Kallapur, Suhas G. Pillow, J. Jane Kramer, Boris W. Jobe, Alan H. Payton, Diane Knox, Christine L. PLoS One Research Article Ureaplasma species are the microorganisms most frequently associated with adverse pregnancy outcomes. The multiple banded antigen (MBA), a surface-exposed lipoprotein, is a key virulence factor of ureaplasmas. The MBA demonstrates size variation, which we have shown previously to be correlated with the severity of chorioamnion inflammation. We aimed to investigate U. parvum serovar 3 pathogenesis in vivo, using a sheep model, by investigating: MBA variation after long term (chronic) and short term (acute) durations of in utero ureaplasma infections, and the severity of chorioamnionitis and inflammation in other fetal tissues. Inocula of 2×10(7) colony-forming-units (CFU) of U. parvum serovar 3 (Up) or media controls (C) were injected intra-amniotically into pregnant ewes at one of three time points: day 55 (69d Up, n = 8; C69, n = 4); day 117 (7d Up, n = 8; C7, n = 2); and day 121 (3d Up, n = 8; C3, n = 2) of gestation (term = 145–150d). At day 124, preterm fetuses were delivered surgically. Samples of chorioamnion, fetal lung, and umbilical cord were: (i) snap frozen for subsequent ureaplasma culture, and (ii) fixed, embedded, sectioned and stained by haematoxylin and eosin stain for histological analysis. Selected fetal lung clinical ureaplasma isolates were cloned and filtered to obtain cultures from a single CFU. Passage 1 and clone 2 ureaplasma cultures were tested by western blot to demonstrate MBA variation. In acute durations of ureaplasma infection no MBA variants (3d Up) or very few MBA variants (7d Up) were present when compared to the original inoculum. However, numerous MBA size variants were generated in vivo (alike within contiguous tissues, amniotic fluid and fetal lung, but different variants were present within chorioamnion), during chronic, 69d exposure to ureaplasma infection. For the first time we have shown that the degree of ureaplasma MBA variation in vivo increased with the duration of gestation. Public Library of Science 2013-04-26 /pmc/articles/PMC3637154/ /pubmed/23638142 http://dx.doi.org/10.1371/journal.pone.0062746 Text en © 2013 Robinson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Robinson, James W. Dando, Samantha J. Nitsos, Ilias Newnham, John Polglase, Graeme R. Kallapur, Suhas G. Pillow, J. Jane Kramer, Boris W. Jobe, Alan H. Payton, Diane Knox, Christine L. Ureaplasma parvum Serovar 3 Multiple Banded Antigen Size Variation after Chronic Intra-Amniotic Infection/Colonization |
title |
Ureaplasma parvum Serovar 3 Multiple Banded Antigen Size Variation after Chronic Intra-Amniotic Infection/Colonization |
title_full |
Ureaplasma parvum Serovar 3 Multiple Banded Antigen Size Variation after Chronic Intra-Amniotic Infection/Colonization |
title_fullStr |
Ureaplasma parvum Serovar 3 Multiple Banded Antigen Size Variation after Chronic Intra-Amniotic Infection/Colonization |
title_full_unstemmed |
Ureaplasma parvum Serovar 3 Multiple Banded Antigen Size Variation after Chronic Intra-Amniotic Infection/Colonization |
title_short |
Ureaplasma parvum Serovar 3 Multiple Banded Antigen Size Variation after Chronic Intra-Amniotic Infection/Colonization |
title_sort | ureaplasma parvum serovar 3 multiple banded antigen size variation after chronic intra-amniotic infection/colonization |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637154/ https://www.ncbi.nlm.nih.gov/pubmed/23638142 http://dx.doi.org/10.1371/journal.pone.0062746 |
work_keys_str_mv | AT robinsonjamesw ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT dandosamanthaj ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT nitsosilias ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT newnhamjohn ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT polglasegraemer ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT kallapursuhasg ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT pillowjjane ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT kramerborisw ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT jobealanh ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT paytondiane ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization AT knoxchristinel ureaplasmaparvumserovar3multiplebandedantigensizevariationafterchronicintraamnioticinfectioncolonization |